biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by KayakerBCon Dec 31, 2015 4:58pm

357 Views

Post# 24423036

Best Guesses for 2016

OK, just for fun, what are your best guesses for the following....

1. BTI share price, market close, last trading day of 2016.

2. Number of license agreements/deals. These are money deals. (Not TAAs. Not agreements like Harvard or Brains for Brain (Scarpa).)

Once all the guesses are in, I'll post the list.

Deadline: Unless you're away and have a really good excuse, all guesses in before market open Jan 4th, 2016.

Mine:

1. Share Price: $4.50
2. N of deals: 3

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!